Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol
Metabolic-(non-alcoholic) associated fatty liver disease (MAFLD/NAFLD) has increasingly become a worldwide epidemic. It has been suggested that renaming NAFLD to MAFLD is critical in identifying patients with advanced fibrosis and poor cardiovascular outcomes. There are concerns that the progression...
Main Authors: | Consolato M. Sergi, Mohit Kehar, Carolina Jimenez-Rivera |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2024-02-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/20420188241227766 |
Similar Items
-
Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD)
by: Ying Zhao, et al.
Published: (2023-12-01) -
Therapeutics for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)
by: Kamlesh K. Bhopale, et al.
Published: (2023-10-01) -
Polysaccharides: The Potential Prebiotics for Metabolic Associated Fatty Liver Disease (MAFLD)
by: Qin Guo, et al.
Published: (2023-08-01) -
Fibrogenic Pathways in Metabolic Dysfunction Associated Fatty Liver Disease (MAFLD)
by: Pallavi Subramanian, et al.
Published: (2022-06-01) -
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease
by: Anand V. Kulkarni, et al.
Published: (2023-06-01)